The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $632,100 in first-year total cost, median $208,148.
Most frequent study sections
- Special Emphasis Panel[ZCA1 TCRB-U (J1)]2
- Special Emphasis Panel[ZCA1 GRB-P (A1)]1
Most frequent institutions
- CEDARS-SINAI MEDICAL CENTER1
- PENNSYLVANIA STATE UNIVERSITY, THE1
- STATE UNIVERSITY OF NEW YORK AT BUFFALO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | (PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women1R21CA194626-01 | ORSULIC, SANDRA | CEDARS-SINAI MEDICAL CENTER, CA | $227,288 | ZCA1 |
| 2015 | (PQA2) A NEW TOOL FOR CANCER PROGNOSTICATION BASED ON ALTERING VASCULAR HOMOEOSTASIS1R21CA194634-01 | SEN, ARINDAM | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $208,148 | ZCA1 |
| 2014 | (PQA1) FMRI Neurofeedback and Descision-Making in Habitual Cigarette Smokers1R21CA190093-01 | WILSON, STEPHEN JEFFREY | PENNSYLVANIA STATE UNIVERSITY, THE, PA | $196,664 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.